TMPRSS3 Inhibitors

Chemical inhibitors of TMPRSS3 can block the protein's enzymatic activity through various mechanisms. Camostat Mesylate and Nafamostat Mesylate function by directly binding to the serine protease domain of TMPRSS3, which is essential for its proteolytic function. This binding effectively prevents TMPRSS3 from cleaving and activating other proteins that play roles in viral entry into host cells. Similarly, Bromhexine Hydrochloride interferes with the proteolytic action of TMPRSS3, disrupting processes that are vital for the fusion of viral and cellular membranes. On the other hand, Nafamostat, without the mesylate group, also engages with the active site of TMPRSS3, obstructing the enzyme's function that facilitates the priming of viral spike proteins, which is a critical step in viral entry into the host cells.

In addition to these inhibitors, Gabexate Mesylate and Aprotinin inhibit TMPRSS3 by blocking its serine protease activity, crucial for processing viral envelope glycoproteins. Aprotinin forms a reversible complex with TMPRSS3, which hinders the activation of viral proteins necessary for cell entry. Leupeptin Hemisulfate also reversibly binds to the active site of TMPRSS3, impeding its activity. This is critical because TMPRSS3 is involved in activating viral proteins that are prerequisites for viral entry. E-64 takes a more permanent approach by irreversibly binding to TMPRSS3, preventing the proteolytic activation of viral fusion proteins. Phenylmethylsulfonyl Fluoride (PMSF) and AEBSF Hydrochloride both react with the serine residue in the active site, leading to irreversible inactivation of TMPRSS3's protease activity. PMSF achieves this by modifying the serine residue, while AEBSF Hydrochloride covalently modifies the residue, both resulting in the loss of TMPRSS3 activity. Finally, 3,4-Dichloroisocoumarin and Pepstatin A inhibit TMPRSS3 by targeting the active site. 3,4-Dichloroisocoumarin binds to the active site serine, while Pepstatin A interacts with aspartic residues, both inactivating the proteolytic function necessary for processing viral proteins, thereby inhibiting TMPRSS3.